Close
FINDING CURES TOGETHER<sup>SM</sup>

CIMM Election Results

Congratulations to Sandra Demaria, MD, CIMM Chairperson-elect 2019-2020

Our thanks to Kunle Odunsi, MD, PhD, and Sandra Demaria, MD, for standing for election and to the membership of CIMM for participating in the election. Congratulations to Dr. Demaria for having been elected as CIMM chairperson-elect. Dr. Demaria will assume the office of chairperson-elect at the AACR Annual Meeting 2019, March 29-April 3, in Atlanta, Georgia.

Sandra Demaria, MD
Professor of Radiation Oncology and Pathology and Laboratory Medicine
Department of Radiation Oncology
Weill Cornell Medical College
New York, New York

Education:
1988
MD, Medical School of the Univeristy of Turin, Italy

Research Interests/Vision Statement:
I am a physician trained in pathology and a translational immunologist who has devoted my career to identifying new ways to elicit therapeutically effective anti-tumor immune responses. To pursue this goal, I worked with investigators from other disciplines to test the unlikely hypothesis that radiotherapy could be used to elicit anti-tumor immune responses. Our initial demonstration of radiation-enhanced responses to anti-CTLA-4 antibody in preclinical tumor models almost fifteen years ago has now been translated in cancer patients. The central goal of my lab is to address the molecular mechanisms that regulate ionizing radiation’s ability to generate an in situ tumor vaccine and overcome resistance to cancer immunotherapy.

Immunotherapy has transformed cancer care and galvanized the interest of physicians and scientists from multiple disciplines. While very exciting, there is much to be learned about the interaction of cancer with the immune system, and about how to ignite anti-tumor immunity in patients who do not respond to treatment. A multidisciplinary team approach has never been more important. The Cancer Immunology Working Group (CIMM) is an ideal forum to catalyze collaborations that leverage the incredible breath of scientific expertise present within AACR.  In addition, CIMM provides leadership in educational activities and the opportunity for networking and mentorship of young investigators. As Chairperson, I will foster the goals of CIMM and AACR to promote the most innovative and impactful basic, translational and clinical research in cancer immunology and immunotherapy, through education, scientific discussion at meetings and advocacy for sustained support of research and innovation.